Oncotarget | Interview with Dr. Alex Toker & Dr. Maria Mancini from Beth Israel Deaconess Medical Center with Harvard Medical School talking about their featured cover paper in Oncotarget - "Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis"
Oncotarget is a weekly, peer-reviewed, open access Journal covering research on all aspects of oncology. Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types and even tissues that can be viewed as targets relevant to cancer and other diseases as well. The term was introduced in the inaugural Editorial "Introducing OncoTarget" http://bit.ly/Introducing-Oncotarget